As of January 2025, Genexine has a market cap of $152.34M. This makes Genexine the world's 17715th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $242.72M | -13.74% |
2023 | $281.38M | -46.92% |
2022 | $530.07M | -68.01% |
2021 | $1.66B | -25.16% |
2018 | $2.21B | 6.71% |
2017 | $2.07B | 69.18% |
2016 | $1.23B | -8.09% |
2015 | $1.33B | 97.27% |
2014 | $676.44M | 75.00% |
2013 | $386.54M | 51.11% |
2012 | $255.80M | - |